Atom | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Dates: April 5, 2025 (New, Renewal, Resubmission, Revision) | September 5, 2025 (New, Renewal, Resubmission, Revision)

Funding Amounts: Phase I: up to $300,000 total costs (1 year) | Phase II: up to $2,000,000 total costs (up to 3 years)

Summary: Supports small businesses in translating biomedical and behavioral research results in arthritis, musculoskeletal, and skin diseases from academic/non-profit labs to the marketplace; clinical trials are not allowed.

Key Information: Requires collaboration and technology transfer agreement between academic/non-profit labs and small businesses; only U.S. small businesses are eligible.

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

Sign in to see full grant listing